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ABSTRACT Protein folding in the endoplasmic reticulum (ER) is error prone, and ER quality 
control (ERQC) processes ensure that only correctly folded proteins are exported from the 
ER. Glycoproteins can be retained in the ER by ERQC, and this retention contributes to mul-
tiple human diseases, termed ER storage diseases. UDP-glucose:glycoprotein glucosyltrans-
ferase (UGGT1) acts as a central component of glycoprotein ERQC, monoglucosylating de-
glucosylated N-glycans of incompletely folded glycoproteins and promoting subsequent 
reassociation with the lectin-like chaperones calreticulin and calnexin. The extent to which 
UGGT1 influences glycoprotein folding, however, has only been investigated for a few se-
lected substrates. Using mouse embryonic fibroblasts lacking UGGT1 or those with UGGT1 
complementation, we investigated the effect of monoglucosylation on the soluble/insoluble 
distribution of two misfolded α1-antitrypsin (AAT) variants responsible for AAT deficiency 
disease: null Hong Kong (NHK) and Z allele. Whereas substrate solubility increases directly 
with the number of N-linked glycosylation sites, our results indicate that additional solubility 
is conferred by UGGT1 enzymatic activity. Monoglucosylation-dependent solubility decreases 
both BiP association with NHK and unfolded protein response activation, and the solubility 
increase is blocked in cells deficient for calreticulin. These results suggest that UGGT1-depen-
dent monoglucosylation of N-linked glycoproteins promotes substrate solubility in the ER.
INTRODUCTION
Although the amino acid sequence of a protein has all the information 
required for it to fold into its native functional conformation (Anfinsen, 
1973), folding pathways and efficiency are dramatically influenced 
by the environment (Braakman and Bulleid, 2011). Newly made 
secretory and transmembrane proteins in the endoplasmic reticulum 
(ER) require the assistance of chaperones and enzymes to fold into 
their native conformation (Braakman and Bulleid, 2011). Recognition, 
retention, refolding, and degradation of misfolded protein substrates 
in the ER are referred to collectively as ER quality control (Ellgaard 
et al., 1999; Trombetta and Parodi, 2003; Hebert and Molinari, 2007; 
Anelli and Sitia, 2008; Braakman and Bulleid, 2011). Protein folding 
failure in the ER can lead to insolubility by either formation of protein 
aggregates or ordered polymerization. Once rendered insoluble in 
the ER, entrapped proteins are degraded (through autophagy) or can 
persist as undegraded insoluble complexes possibly contributing to 
cell toxicity, or they may be resolubilized (Ishida and Nagata, 2009; 
Hidvegi et al., 2010; Rampelt et al., 2012). The mechanisms that pro-
mote protein solubility in the ER are poorly understood.
The folding, trafficking, and degradation of glycoproteins is cou-
pled with the modification of N-linked oligosaccharides (Helenius 
and Aebi, 2004; Hebert and Molinari, 2012). On translocation into 
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To directly investigate the effect of UGGT1 on NHK, ATZ, or wild-
type AAT (wt-AAT) solubility, we metabolically labeled Uggt1−/− 
MEFs (or those complemented with plasmid-encoded UGGT1) ex-
pressing these substrates with [35S]methionine/cysteine to approach 
steady state. By quantitative immunoprecipitation (IP; Supplemental 
Figure S1A), we determined that over the course of the metabolic 
labeling period (24 h), a fraction of mutant NHK molecules was se-
creted; a second portion was recovered in the intracellular deter-
gent-soluble supernatant fraction; and a third was recovered as ag-
gregates that failed to be solubilized from Uggt1−/− MEFs lysed in 
nonionic detergents (Figure 1A). This “detergent-insoluble fraction” 
was indeed solubilized in SDS-containing detergent extracts.
Whereas endoglycosidase H (EndoH)-resistant NHK molecules 
were found in the secreted fraction, both the soluble and detergent-
insoluble intracellular fractions were EndoH sensitive, indicating that 
neither the soluble nor the insoluble intracellular pool had arrived in 
a Golgi compartment from which they could be further modified by 
Golgi N-glycan processing enzymes (Figure 2D). We confirmed by 
several independent approaches that a fraction of mutant NHK mol-
ecules forms detergent-insoluble protein aggregates. First, pulse-
chase experiments demonstrated that newly synthesized NHK was 
not initially recovered in the detergent-insoluble fraction but be-
came so as a function of chase, indicating time-dependent specific-
ity (Figure 2C). Second, we compared solubility of NHK using three 
standard detergent lysis methods that have been used for analysis 
of AAT and its variants (Schmidt and Perlmutter, 2005; Kroeger 
et al., 2009; Galli et al., 2011): 1) 3-[(3-cholamidopropyl)
dimethylammonio]-1-propanesulfonate hydrate (CHAPS; 2% wt/vol); 
2) Nonidet P-40 (1% vol/vol); and 3) Triton X-100 (0.5% wt/vol) and 
sodium deoxycholate (0.5% wt/vol). In each case, a detergent-insol-
uble fraction of NHK was recovered (Supplemental Figure S1B). Fi-
nally, intracellular wt-AAT was always undetectable in the insoluble 
fraction (Figures 1C and 2A), indicating that recovery in the deter-
gent-insoluble pool was not caused by failure to disrupt cellular 
membranes from Uggt1−/− MEFs. These findings, together with 
other results (Greenblatt et al., 2011), provide strong evidence that 
NHK is predisposed to aberrant protein aggregation.
Complementation of Uggt1−/− MEFs with UGGT1 greatly ex-
panded the steady-state intracellular pool of NHK molecules (Figure 
1A). Whereas only half as many NHK molecules were secreted, there 
was a great expansion of the pool of soluble intracellular NHK mol-
ecules (Figure 1A, middle, red bar) and a decrease in the pool of 
detergent-insoluble NHK (Figure 1A, middle, blue bar). In addition, 
the total soluble (extracellular plus soluble)/insoluble NHK ratio in-
creased with UGGT1 cotransfection (Figure 1A, right). Thus the net 
effect of coexpressing UGGT1 was to increase the solubility of NHK.
The same experimental analysis was used to investigate ATZ 
trafficking in the ER. Whereas NHK cannot undergo loop-sheet po-
lymerization, recovery of detergent-insoluble ATZ is believed to 
reflect the formation of ordered polymers (Gooptu et al., 2009). 
Here as well, UGGT1 expression increased the total soluble/insol-
uble ratio of ATZ almost twofold (with little effect on the secreted 
fraction; Figure 1B). In addition, similar to NHK, in pulse-chase ex-
periments, ATZ was not detected in the detergent-insoluble frac-
tion initially but accumulated in the insoluble fraction over time 
(Figure 2B). Furthermore, to directly detect ATZ polymers in trans-
fected cells, we used a recently developed monoclonal antibody 
(2C1) that specifically recognizes ATZ polymers (Miranda et al., 
2010). Immunofluorescence costaining with 2C1 and polyclonal 
anti-AAT antibody and subsequent quantitation of signal intensity 
in the entire cell volume through Z-stack analysis revealed a 
decrease in the ratio of 2C1 to AAT signal in cells cotransfected 
transferred to asparagine residues within the acceptor sequence 
Asn-Xxx-Ser/Thr. Glucosidases I and II sequentially trim this core to 
a monoglucosylated glycan that can mediate binding to lectin-like 
ER chaperones calreticulin (CRT) and calnexin (CNX). Interaction 
with CRT and CNX serves to retain improperly folded substrates in 
the ER as a key step in glycoprotein quality control, as well as to 
promote folding through interactions with ERp57 (Zapun et al., 
1998). On release from CRT/CNX, glucosidase II can remove the 
remaining glucose to produce a product that, if folded properly, 
traffics to the Golgi or, if folded improperly, is directed to ER-associ-
ated degradation (ERAD) or is subject to reglucosylation for interac-
tion with CRT/CNX. Uridine diphosphate (UDP)-glucose:glycoprotein 
glucosyltransferase (UGGT1) is proposed to be a central gatekeeper 
for ER quality control for glycoproteins, as it recognizes the partially 
folded status as a substrate to reglucosylate the deglucosylated N-
glycan to direct another round of interaction with CRT/CNX 
(Maattanen et al., 2010; Hebert and Molinari, 2012).
There are two UGGT genes in mouse, Uggt1 and Uggt2 (Arnold 
et al., 2000). The product of Uggt1 has reglucosylation activity in 
vitro, and its deletion destroys reglucosylation activity in cells and is 
embryonic lethal at day E13 in mice (Molinari et al., 2005). In contrast, 
the product of Uggt2 has not been demonstrated to have reglucosy-
lation activity, and its function is unknown. Of interest, exchange of 
the UGGT1 80% amino-terminal substrate recognition domain into 
UGGT2 partially restores reglucosylation activity in vitro, demonstrat-
ing that the carboxy-terminal 20% of UGGT2 can function as a gluco-
syltransferase in the proper context (Arnold and Kaufman, 2003).
Whereas the purported mechanism for UGGT1-mediated quality 
control—reiterative monoglucosylation of deglucosylated N-glycans 
on incompletely folded glycoproteins, and subsequent rounds of as-
sociation of these glycoproteins with CRT/CNX—has been exten-
sively described (Sousa et al., 1992; Sousa and Parodi, 1995; Parodi, 
2000; Hebert et al., 1995; D’Alessio et al., 2010), the extent to which 
UGGT1 influences the susceptibility of ER substrate proteins to form 
insoluble protein aggregates or polymers is unclear. In this study, we 
use two different α1-antitrypsin (AAT) variants prone to misfolding to 
investigate the effect of UGGT1 on the solubility of these glycopro-
tein substrates. One variant is the well-studied ERAD substrate known 
as null Hong Kong variant (α1-antitrypsin–null Hong Kong variant 
[NHK]); the other is the more common mutant Z allele (α1-antitrypsin 
Z allele variant [ATZ]). Both alleles cause AAT deficiency (the most 
common genetic liver disease in children), which is a representative of 
the class of “conformational diseases” caused by retention of mis-
folded glycoproteins in the ER (Kim and Arvan, 1998; Rutishauser and 
Spiess, 2002; Schroder and Kaufman, 2005; Perlmutter, 2006). In this 
article, using Uggt1−/− mouse embryonic fibroblasts (MEFs) express-
ing NHK or ATZ and complemented with plasmid-encoded UGGT1, 
we demonstrate that UGGT1 enzymatic activity, in conjunction with 
lectin-like chaperones, helps to limit aggregation and polymer forma-
tion of misfolded glycoprotein substrates, decreasing their BiP asso-
ciation and ER stress.
RESULTS
UGGT1 increases the solubility of AAT mutants 
NHK and ATZ
Uggt1−/− MEFs have undetectable levels of UGGT1 protein and en-
zymatic monoglucosylation activity (Molinari et al., 2005). UGGT1 in 
the ER is associated with misfolded NHK and ATZ variants of AAT 
(Choudhury et al., 1997; Schmidt and Perlmutter, 2005). ATZ is pre-
disposed to form insoluble ordered polymers (Gooptu et al., 2009), 
whereas ER-entrapped NHK can be recovered in a detergent-solu-
ble pool in UGGT1-expressing cells (Liu et al., 1997).
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with UGGT1 (Supplemental Figure S2, A 
and B).
Thus, for mutant glycoproteins that are 
prone to misfolding in two distinctly differ-
ent ways (formation of ordered polymers 
[ATZ] or formation of disordered aggregates 
[NHK]), UGGT1 increased substrate solubil-
ity. By contrast, UGGT1 had no significant 
effect on the behavior of wt-AAT, consistent 
with the observation that wt-AAT molecules 
were soluble in Uggt1−/− MEFs even before 
complementation with UGGT1 (Figure 1C).
UGGT1 promotes NHK solubility via 
monoglucosylation activity
To investigate whether increased NHK solu-
bility was due to UGGT1 chaperone func-
tion or enzymatic reglucosylation activity 
(Parodi, 2000), we eliminated the enzymatic 
contribution of UGGT1 either by glucosi-
dase inhibition (with castanospermine [CAS], 
which prevents formation of unglucosylated 
N-glycans that serve as substrates for 
UGGT1-mediated monoglucosylation) or 
complementation with UGGT1 variants lack-
ing monoglucosylation activity. When CAS 
was included throughout the labeling pe-
riod, UGGT1 did not increase solubility of 
NHK (Figure 3A). Furthermore, a catalyti-
cally inactive UGGT1 (lacking six amino ac-
ids within the catalytic site, called ΔUGGT1; 
Arnold et al., 2000) was similarly unable to 
augment the solubility of NHK (Figure 3A). 
A UGGT1/UGGT2 chimera (in which the 
FIGURE 1: UGGT1 increases the solubility of α1-antitrypsin mutants NHK and ATZ. (A–C) The 24-h 
metabolic labeling of Uggt1−/− MEFs transfected with (A) NHK, (B) ATZ, or (C) wt-AAT ± UGGT1 
cotransfection. Uggt1−/− MEFs were transfected with expression vectors encoding the misfolded 
α1-antitrypsin variants NHK or ATZ or wild-type AAT (wt-AAT) and cotransfected with either empty 
vector or UGGT1 expression vector. Cells were radiolabeled from 24 to 48 h posttransfection in 
complete medium plus 10 μCi/ml [35S]methionine/cysteine. Extracellular, soluble, and insoluble 
fractions were produced (Materials and Methods), and TCA-precipitation normalized volumes of 
each fraction were subjected to double–anti-AAT quantitative IP and PNGaseF digestion and 
analyzed by reducing SDS–PAGE and autoradiography. Substrate solubility was calculated by 
dividing total soluble (extracellular + intracellular soluble) substrate amount by insoluble substrate 
amount. Middle, Student’s t test used for statistical testing; right, paired Student’s t test used for 
statistical testing (*p ≤ 0.05). Error bars represent SEM. For ATZ, all UGGT1+ bands were darkened 
with imaging software to make synthesis (data not shown) ± UGGT1 appear equal. FIGURE 2: NHK and ATZ, but not wt-AAT, 
become insoluble over time. (A) Transient 
transfection of Uggt1−/− MEFs with wt-AAT ± 
UGGT1 and analysis by pulse chase at the 
indicated time points (Materials and Methods). 
No wt-AAT was detected in the insoluble 
fraction at any time point. (B) Same as A for 
ATZ. Here ATZ progressively accumulates in 
the insoluble fraction over time. (C) Same 
as A for NHK. Here NHK progressively 
accumulates in the insoluble fraction over 
time. Soluble NHK was run on a nonreducing 
gel because under reducing conditions, the 
reduced IP antibody physically pushes all NHK 
bands down to the same molecular weight. 
For A–C, four times the TCA-normalized 
amount of insoluble fraction was used for IP 
compared with soluble fraction (actual relative 
amount of insoluble ATZ and NHK is 25% of 
what is seen in the gel image). (D) EndoH 
digest of extracellular, soluble, and insoluble 
NHK after steady-state labeling. The majority 
of extracellular NHK is EndoH resistant, 
evidence of having Golgi-modified N-glycans 
typically found on secreted glycoproteins. 
NHK in the soluble and insoluble fractions is 
completely EndoH sensitive, indicating that 
these forms are not modified by Golgi-
localized N-glycan–modifying enzymes.
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2007). Only when Uggt1−/− MEFs were 
complemented with enzymatically active 
glucosyltransferase, however, was the CNX–
NHK association detected (Figure 3B).
To directly establish that increased NHK 
solubility in UGGT1-expressing cells is 
caused by enzymatic monoglucosylation 
activity, we used jack-bean α-mannosidase 
(JBM; an exomannosidase that cleaves 
eight mannose residues from unglucosy-
lated ER-type N-glycans but only five man-
nose residues from monoglucosylated ER-
type N-glycans; Figure 3C) to create 
diagnostic digests to assess the glycosyla-
tion status of steady-state soluble and de-
tergent-insoluble pools. On JBM digestion, 
intracellular soluble NHK from UGGT1-
expressing MEFs produced a predominant 
higher–molecular mass digestion product 
distinct from the primary form recovered in 
Uggt1−/− MEFs (Figure 3D, left). By contrast, 
in spite of UGGT1 expression, intracellular 
detergent-insoluble NHK, upon JBM diges-
tion, produced a predominant lower–
molecular mass digestion product that 
comigrated with that from UGGT1-deficient 
MEFs (Figure 3D, right). Strikingly, upon 
UGGT1 complementation, the majority of 
detergent-insoluble NHK lacks monogluco-
sylated N-glycans, whereas the majority of 
soluble NHK from the same cells bear 
monoglucosylated N-glycans. The findings 
strongly suggest that increased solubility 
of the substrate is a consequence of its 
N-glycan monoglucosylation.
UGGT1 maintains solubility of NHK 
over time
As noted, all newly synthesized NHK, ATZ, 
and wt-AAT molecules begin in the soluble 
fraction; thus the accumulation of NHK and 
ATZ molecules takes time. Although 
steady-state labeling provides useful con-
ditions for determining the sizes of soluble 
and insoluble intracellular pools, it does 
not provide insight into the entry or exit of 
molecules in these fractions. Therefore, af-
ter steady-state labeling, we followed pools of NHK for up to 6 h 
in the absence of further metabolic labeling. As previously ob-
served (Figure 1A), intracellular NHK solubility was enhanced in 
UGGT1-expressing cells (Figure 4, A and B). At 3 and 6 h after the 
steady-state labeling period, the pool of soluble NHK decreased 
in Uggt1−/− MEFs both without and with UGGT1 complementa-
tion. Without UGGT1 complementation, however, some of the 
molecules formerly in the soluble pool entered and expanded the 
detergent-insoluble pool (Figure 4, A and B), whereas in the pres-
ence of UGGT1, expansion of the detergent-insoluble pool was 
prevented. Indeed, despite a decrease in soluble NHK as a func-
tion of chase time, the relative increase in NHK solubility as a con-
sequence of UGGT1 activity was maintained at all times (Figure 
4C). Thus the results suggest that UGGT1 activity limits misfolded 
glycoprotein entry into detergent-insoluble complexes.
C-terminal 20% of UGGT2 replaced the C-terminal 20% of UGGT1), 
however, bearing approximately half of the enzymatic activity of na-
tive UGGT1 (Arnold and Kaufman, 2003) increased NHK solubility, 
and this effect was similarly eliminated by CAS treatment (Figure 
3A). Of importance, these various UGGT1 constructs were expressed 
at comparable levels (Supplemental Figure S4). In parallel to these 
NHK results, we found that enhanced solubility of ATZ also corre-
lated with the presence of enzymatic UGGT1 monoglucosylation 
activity (Supplemental Figure S3).
Because lectin-like chaperones CRT and CNX recognize mono-
glucosylated N-glycans, as an indirect measure of monoglucosyla-
tion we examined NHK association with CNX at the end of the 24-h 
metabolic labeling of Uggt1−/− MEFs ± UGGT1 complementation. 
As in previous experiments, 2% CHAPS was included in the cell ly-
sis buffer to maintain CNX–substrate interactions (Solda et al., 
FIGURE 3: UGGT1 promotes solubility of NHK through monoglucosylation activity. 
(A) Cotransfection with NHK and UGGT1 engineered variants and analysis of NHK. After 24 h 
metabolic labeling in the presence or absence of glucosidase inhibitor castanospermine, total 
soluble/insoluble ratios of NHK were determined. An increased total soluble/insoluble ratio was 
observed only when UGGT1 reglucosylation activity was expected, and this effect was blocked 
by glucosidase inhibition. Error bars represent SEM. (B) Estimate of the proportion of soluble 
NHK associated with CNX in the various experimental conditions from A. Soluble material was 
subjected to anti-CNX/anti-AAT antibody tandem IP and anti-AAT antibody double IP. 
Appreciable NHK was only detected after anti-CNX/anti-AAT tandem IP when UGGT1 
reglucosylation activity and monoglucosylated substrate was expected. (C) JBM and UGGT1 
activity. (D) JBM digestion of N-glycans on NHK immunopurified from 24-h-labeled soluble and 
insoluble fractions. Bands corresponding to monoglucosylated or unglucosylated N-glycans are 
as indicated. Soluble and insoluble fractions were run on the same gel, but insoluble bands were 
darkened with imaging software to appear similarly dense to soluble bands.
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ERAD inhibition increases UGGT1-dependent NHK solubility
To investigate whether NHK is degraded by ERAD during the course 
of our experiments, we treated NHK-transfected cells with kifun-
ensine (KIF; a mannosidase inhibitor) for the entire 24-h metabolic 
labeling period. KIF potently inhibits glycoprotein ERAD (Tokunaga 
et al., 2000), including the degradation of NHK (Brodsky, 2007; 
Hosokawa et al., 2007). By measuring the amount of steady-state 
NHK recovered in all fractions and normalizing this total to its syn-
thesis in the same cells, we could deduce the amount of NHK de-
graded under each experimental condition (Figure 5, A and B). 
When KIF was present, the amount of NHK recovered in the insolu-
ble fraction increased, both with and without UGGT1 cotransfection 
(Figure 5, A and B). In the presence of UGGT1, however, KIF treat-
ment also promoted an increase in total soluble NHK (Figure 5, 
A–C). Similarly, a pulse-chase technique showed that when UGGT1 
was present, KIF treatment stabilized soluble NHK in cells (Figure 
5D). Of interest, this KIF-induced increase in soluble NHK was not 
seen in Uggt1−/− MEFs cotransfected with empty vector (Figure 5B). 
Given that ERAD inhibition expands NHK solubility caused by 
UGGT1 activity, the effect of UGGT1 to promote the solubility of 
NHK in the absence of ERAD inhibition is likely to be larger than the 
magnitude shown in Figures 1–3.
Relative contribution of N-glycan addition versus that 
of monoglucosylation to the solubility of misfolded 
mutant AAT
NHK, ATZ, and wt-AAT all have three N-linked glycosylation sites at 
positions N46, N83, and N247. To investigate the contribution of 
each of these N-glycans to NHK solubility, we eliminated N-glycosy-
lation at these sites by mutagenizing each Asn acceptor to Gln and 
prepared all possible combinations of one-site or two-site N-glyco-
sylation mutants. We then measured the total soluble/insoluble ra-
tio for each of the seven constructs with or without UGGT1 comple-
mentation (Figure 6, A and B). The majority of unglycosylated NHK 
(NHK-N46Q_N83Q_N247Q or NHKQQQ) was insoluble, and 
UGGT1 cotransfection had no effect on the solubility of this con-
struct (Figure 6B, bars 1 and 2). For the NHK constructs with only 
one N-glycosylation site (NHK-N83Q_N247Q, NHK-N46Q_N247Q, 
and NHK-N46Q_N83Q), in the absence of UGGT1, solubility did 
not increase, but solubility was enhanced by expression of UGGT1 
(Figure 6B, bars 3–8). The largest UGGT1-mediated solubility in-
crease occurred with the NHK-N46Q_N247Q mutant, perhaps indi-
cating particular importance of the N83 N-glycan (Figure 6B, bars 5 
and 6). For the NHK constructs with two N-glycosylation sites (NHK-
N247Q, NHK-N83Q, NHK-N46Q), solubility increased both with 
and without UGGT1, but the increase was greater when UGGT1 was 
present (Figure 6B, bars 9–14), and each of the double-glycan mu-
tants behaved comparably. Similar to Figure 1A, the fully glycosy-
lated protein was the most soluble NHK construct, but UGGT1 ex-
pression conferred additional solubility (Figure 6B, bars 15 and 16). 
The results indicate that each N-linked glycan contributes to the 
solubility of NHK, but maximal solubility is achieved only in UGGT1-
expressing cells.
UGGT1 cotransfection reduces NHK association with BiP 
and BiP-luciferase response
The binding of unfolded and misfolded proteins in the ER to BiP 
activates the unfolded protein response (UPR; Dorner et al., 1987, 
1989; Malhotra and Kaufman, 2007). To examine BiP association 
with NHK, we analyzed dithiobis succinimidyl propionate (DSP)–
cross-linked cell lysates by immunoprecipitation with anti-AAT and 
subjected the immunoprecipitates to reducing SDS–PAGE and 
FIGURE 4: UGGT1 maintains increased total soluble/insoluble ratio 
for NHK during 6-h chase after 24-h labeling. (A) The 24-h labeling 
and chase analysis of NHK. After 24-h labeling, cells were chased with 
unlabeled media for 3 or 6 h, and then extracellular, soluble, and 
insoluble fractions were subjected to anti-AAT double IP. The amount 
of newly synthesized NHK recovered from 20-min pulse labeling was 
used to quantify NHK synthesis for normalization. (B) Total amount of 
NHK remaining in each fraction after chase, normalized to synthesis. 
Error bars represent SEM. (C) Plot of total soluble/insoluble NHK at 
0-, 3-, and 6-h chase points. Student’s t test was used for statistical 
testing (*p ≤ 0.05). Error bars represent SEM.
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immunoblotting with anti-BiP and anti-AAT. Consistent with the 
metabolic labeling results of Figure 1A, there was increased NHK in 
the soluble fraction of Uggt1−/− MEFs complemented with UGGT1 
(Figure 7A, bottom). Despite the fact that there was more NHK pres-
ent in the soluble pool, however, the actual amount of BiP associ-
ated with NHK in that pool decreased (Figure 7A; quantified in B). 
To investigate UPR activation in cells expressing NHK, ATZ, or wt-
AAT, we coexpressed BiP-luciferase and normalized the signal from 
the ER stress response reporter directly to the abundance of the 
misfolded protein substrate. Of interest, neither wt-AAT nor mutant 
ATZ expression (data not shown) increased BiP-luciferase activity, 
regardless of the presence or absence of UGGT1 expression (Figure 
7C, bars 1 and 2), consistent with previous reports (Graham et al., 
1990; Hidvegi et al., 2005, 2007). By contrast, NHK expression in-
duced an appreciable BiP-luciferase response that was attenuated 
in cells complemented with UGGT1 (Figure 7C, bars 3 and 4). Of 
note, UGGT1 complementation did not diminish (and actually aug-
mented) UPR activation to tunicamycin treatment, presumably be-
cause of the increased protein load in the ER and the fact that reg-
lucosylation activity is irrelevant in cells in which N-linked glycosylation 
has been blocked by tunicamycin (Figure 7C, bars 5 and 6). Taken 
together, the results of Figure 7 indicate that BiP association with a 
misfolded glycoprotein substrate decreases as a consequence of 
substrate monoglucosylation, which reduces UPR activation in these 
cells.
The ER lectin calreticulin is linked to increased solubility 
of monoglucosylated glycoprotein substrate
To explore whether UGGT1-mediated solubility of NHK is due to 
increased interaction with lectin-like chaperones, we performed 
CRT small interfering RNA (siRNA)–mediated knockdown in Uggt1−/− 
MEFs (CRT, the most abundant soluble ER lectin, is likely to interact 
with a high fraction of soluble glycoprotein substrates). Because 
calreticulin–substrate association is weak, we used DSP cross-linking 
to stabilize NHK–CRT interactions that might otherwise be lost when 
washing the immunoprecipitated beads (Patil et al., 2000). In both 
DSP cross-linked and non–cross-linked cell lysates, interaction be-
tween NHK and CRT was readily demonstrated (Figure 8A). CRT 
siRNA knockdown (KD) was > 50% efficient in Uggt1−/− MEFs at 48 h 
post-siRNA treatment, and this did not up-regulate other ER chap-
erones, as well as CNX (Figure 8B). On NHK transfection in these 
cells, however, CRT KD largely blocked the increase of NHK solubil-
ity caused by UGGT1 complementation (Figure 8, C–E). In addition, 
CRT KD increased the proportion of insoluble NHK and blocked the 
effect of UGGT1 to decrease the proportion of insoluble NHK 
(Figure 8D). The data indicate that abundance of CRT is a key factor 
in promoting solubility of monoglucosylated N-linked glycoprotein 
substrates in the ER.
DISCUSSION
Protein solubility, or, more important, the formation of insoluble 
protein aggregates or polymers, is believed to play a fundamental 
role in the pathology of a wide array of human diseases (Balch 
et al., 2008). Mutations in secreted proteins can disrupt their nor-
mal ER folding program, resulting in aggregation and cell stress/
death (Wu and Kaufman, 2006; Wang and Kaufman, 2012; Menon 
et al., 2007). Regulation of aggregate/polymer formation and the 
FIGURE 5: ERAD inhibition increases UGGT1-dependent NHK 
solubility. (A) Effect of kifunensine on intracellular NHK. After 
cotransfection with NHK and UGGT1, 24-h metabolic labeling, and 
treatment with the mannosidase inhibitor kifunensine, amounts of 
NHK in extracellular, soluble, and insoluble fractions were determined. 
Amount of newly synthesized NHK recovered from 20-min pulse 
labeling was used to quantify NHK synthesis for normalization. 
(B) Quantification of NHK in extracellular, soluble, and insoluble 
fractions, normalized to synthesis. Error bars represent SEM. (C) Total 
soluble NHK from B, with UGGT1 cotransfection, with and without 
kifunensine treatment. Error bars represent SEM. (D) Pulse-chase 
experiment demonstrating effect of kifunensine to limit degradation 
of soluble NHK when UGGT1 is present.
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the consequences of this increased solubil-
ity were different for NHK and ATZ. For 
NHK, soluble nonnative forms were retained 
in the ER, and the secretion rate was lower 
upon UGGT1 complementation; thus 
UGGT1 increases quality control for secre-
tion of nonnative NHK. For ATZ, UGGT1 re-
tained soluble nonnative forms in the ER 
and decreased the rate of entry into the in-
soluble fraction without altering secretion. 
In parallel with these biochemical studies, 
the amount of ATZ recognized by a polymer-
specific antibody also decreased upon 
UGGT1 complementation (Supplemental 
Figure S2, A and B). The reason for solubility 
affecting trafficking of NHK and ATZ in dif-
ferent ways was not elucidated by this study 
but likely involves different maturation path-
ways for the two proteins, possibly depen-
dent on retentive ER chaperone interactions 
and/or interactions with ER exit complexes.
Of importance, our results demonstrate 
from multiple independent approaches that 
UGGT1 requires its reglucosylation activity 
to promote NHK solubility. First, castano-
spermine treatment, which blocks glucose 
removal from N-glycans and prevents the 
formation of unglucosylated N-glycan sub-
strates for UGGT1, decreased UGGT1-
mediated solubility. Second, overexpression 
of a catalytically inactive UGGT1 enzyme 
did not increase NHK solubility. In contrast, 
NHK solubility was increased by expression 
of a chimeric UGGT1/UGGT2 protein that 
contains the 20% carboxy-terminal catalytic 
domain of UGGT2 (Arnold and Kaufman, 
2003). Of interest, although UGGT2 does 
not have reglucosylation activity in vitro, the 
chimeric protein harboring the catalytic do-
main of UGGT2 can function to promote 
substrate solubility (Figure 3A). Finally, 
UGGT1 had no effect on the solubility of 
NHK with all three N-glycosylation sites dis-
rupted, which prevents formation of the 
UGGT1 substrate (Figure 6, A and B).
To characterize the eventual fate of NHK 
molecules in the soluble and insoluble fractions, we performed ex-
periments with 6-h chase after 24-h labeling. Of interest, insoluble 
NHK was quite stable over a 6-h chase and actually increased in 
amount with time in the absence of UGGT1, with soluble molecules 
entering the insoluble fraction (Figure 4, A and B). Theoretically, the 
amount of NHK in the insoluble fraction after 24 h is determined by 
three processes: 1) entry from the soluble fraction, 2) degradation of 
insoluble forms, and 3) solubilization of insoluble forms to enter the 
soluble fraction. Of interest, monoglucosylated NHK was not de-
tected in the insoluble fraction (Figure 3D), indicating that UGGT1 
cannot reglucosylate molecules that entered the insoluble fraction, 
and therefore UGGT1 may not promote actual resolubilization. We 
cannot rule out the possibility, however, that insoluble molecules 
that are reglucosylated may immediately reenter the soluble frac-
tion and thus are not detected in the insoluble fraction based on 
jack-bean α-mannosidase digestion. Another possibility for the 
role of chaperone interaction in this process are incompletely un-
derstood. In this article we describe how UGGT1 enzymatic activity 
correlates with increased solubility of two model glycoproteins sus-
ceptible to aggregation and polymerization.
A large body of work has delineated the key role of UGGT1 in 
reglucosylation of nonnative glycoprotein folding intermediates and 
subsequent reassociation with the lectin-like chaperones CRT and 
CNX (Sousa et al., 1992; Sousa and Parodi, 1995; Parodi, 2000; 
Hammond et al., 1994; Hebert et al., 1995; Cannon and Helenius, 
1999; D’Alessio et al., 2010). Here we show that the ATZ allele of 
AAT, which is prone to misfolding, formed more insoluble polymers 
in UGGT1-deficient cells (Figure 1B). The NHK variant of AAT also 
accumulated in the insoluble fraction, and the proportion detected 
in the insoluble pool after 24 h of labeling decreased in the pres-
ence of UGGT1 activity (Figure 1A). Of interest, UGGT1 maintained 
the solubility of both nonnative ER forms of these AAT variants, but 
FIGURE 6: UGGT1-mediated solubility of NHK requires N-glycan on NHK. (A) Analysis of NHK 
N-glycosylation mutants in transfected Uggt1−/− MEFs. Uggt1−/− MEFs were transfected with 
expression vectors encoding NHK N-glycosylation–site mutants with all combinations of the 
three N-glycosylation sites mutated (Asp(N) to Gln(Q); 1, NHK-N46,83,247QQQ; 2, NHK-
N83,247QQ; 3, NHK-N46,247QQ; 4, NHK-N46,83QQ; 5, NHK-N247Q; 6, NHK-N83Q; 7, 
NHK-N46Q), cotransfected with either empty vector or UGGT1 expression vector, and 
subjected to steady-state labeling analysis. (B) Quantification of three replicates of experiment 
in A. A significant portion of the increased solubility of NHK with increasing number of 
N-glycans added is due to UGGT1 reglucosylation activity. Student’s t test was used for 
statistical testing (*p ≤ 0.05). Asterisks directly above bars indicate a significant difference in 
total soluble/insoluble ratio between that bar and nonglycosylated NHK (NHKQQQ), either with 
or without UGGT1 cotransfection. Error bars represent SEM.
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absence of monoglucosylated NHK in the insoluble fraction, based 
on a previous finding that NHK is found in ER subcompartments 
called inclusion bodies (Zuber et al., 2007), is that NHK may be 
physically sequestered away from UGGT1. Finally, perhaps the in-
soluble NHK forms a tight aggregate such that the recognition site 
for UGGT1 is not exposed.
Because ERAD is believed to require soluble substrates for 
degradation (Nakatsukasa and Brodsky, 2008), the finding that 
UGGT1 promotes glycoprotein solubility could have implications 
for the degradation of glycoproteins in the ER. Indeed, upon 
ERAD inhibition with kifunensine, total soluble NHK increased, 
and this effect was most prominent when UGGT1 was present 
(Figure 5, A–C). Insoluble NHK also seemed to increase upon 
ERAD inhibition, presumably due to the greater amount of soluble 
NHK available for entry into the insoluble fraction (although we 
cannot rule out that kifunensine may directly inhibit degradation 
of insoluble NHK).
Another finding from this study involves the contribution of the 
three N-glycans of NHK to its solubility. First, we found that al-
though solubility of NHK did increase directly by adding hydro-
philic N-glycans to the polypeptide, a major fraction of this solubi-
lization was UGGT1 dependent (Figure 6, A and B). This indicates 
that, at least for NHK, UGGT1-mediated reglucosylation contrib-
utes to substrate solubility, in addition to solubility afforded by add-
ing hydrophilic N-glycans to the hydrophobic polypeptide. CRT 
knockdown greatly decreased NHK solubilization in response to 
UGGT1 enzymatic activity (Figure 8, C–E). From this, we infer that 
this UGGT1-dependent solubilization effect is due to reassociation 
with CRT/CNX and is not a direct contribution from the glucose 
added to the N-glycan A-chain.
The CNX cycle hypothesis (Hammond et al., 1994) proposes 
that UGGT1 reglucosylates nonnative glycoprotein folding inter-
mediates and promotes their reassociation with CRT/CNX for fur-
ther folding attempts. We directly tested how BiP interaction is in-
volved in UGGT1-enhanced NHK solubility. We showed that, 
whereas the amount of soluble NHK increased with UGGT1 overex-
pression, the amount of BiP bound to soluble NHK clearly de-
creased (Figure 7, A and B). This appears to be an example of BiP 
acting as a second-level ER quality controller for glycoproteins 
when interaction with their primary set of chaperones is disturbed 
(Molinari et al., 2002, 2005).
The role of UGGT1 in glycoprotein trafficking is intimately 
linked with the lectin-like chaperones CNX and CRT (D’Alessio 
et al., 2010). Previous studies implied that NHK does not interact 
with calreticulin (Oda et al., 2003; Cameron et al., 2009); we found, 
however, that NHK extensively associates with CRT in Uggt1−/− 
MEFs cotransfected with NHK and UGGT1 (Figure 8A). siRNA-
mediated CRT knockdown strikingly reduced the ability of UGGT1 
to increase NHK solubility (Figure 8, C–E). The fact that >99% of 
intracellular CRT resides in the soluble fraction (data not shown) 
presumably explains its ability to promote the solubility of monog-
lucosylated NHK.
The mechanisms governing protein solubility and quality control 
in the ER are incompletely understood, but this study highlights how 
the ER enzyme UGGT1 can improve glycoprotein quality control by 
promoting solubility of glycoprotein substrates that are prone to 
misfolding (Figure 9). Our results contribute to the CNX cycle theory 
by demonstrating that UGGT1-dependent lectin interaction can in-
crease glycoprotein substrate solubility in the ER. Further studies on 
the effect of glycan modifications and chaperone interactions should 
provide additional clues to the mechanism(s) maintaining solubility 
of glycoproteins during ER folding.
FIGURE 7: UGGT1 cotransfection reduces NHK association with BiP 
and reduces expression from the BiP promoter. (A) Amount of BiP 
associated with NHK determined by immunoblotting of soluble material 
from DSP-cross-linked Uggt1−/− MEFs, with or without UGGT1 
cotransfection, with anti-BiP or anti-AAT antibodies. (B) Quantification of 
three replicates of experiment in A. UGGT1 cotransfection reduces the 
amount of BiP associated with NHK per molecule. Error bars represent 
SEM. (C) BiP-luciferase response to transient transfection of NHK or 
wt-AAT normalized to total intracellular (soluble + insoluble) amount of 
AAT (we determined that expression of a cotransfected Renilla 
luciferase is an inappropriate tool for BiP-luciferase normalization). 
Tunicamycin treatment (6 h, 5 μg/ml) was included in cells transfected 
with AAT as a control for UPR activation. Student’s t test was used for 
statistical testing (*p ≤ 0.05). Error bars represent SEM.
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MATERIALS AND METHODS
Reagents and antibodies
Castanospermine was from Tocris Biosci-
ence (Ellisville, MO). Kifunensine was from 
Cayman Chemical (Ann Arbor, MI). Protein 
A–Sepharose, CHAPS, N-ethylmaleimide 
(NEM), phenylmethanesulfonyl fluoride 
(PMSF), leupeptin, antipain, pepstatin A, 
DSP, and JBM were from Sigma-Aldrich (St. 
Louis, MO). Chymostatin was from VWR 
(Radnor, PA). EndoH and PNGaseF were 
from New England BioLabs (Ipswich, MA). 
Rabbit anti-AAT antibody was from DAKO 
(Carpinteria, CA). Mouse monoclonal anti-
body (mAb) anti-KDEL and rabbit anti-CNX 
(used for immunoblotting) were from Enzo 
Life Sciences (Plymouth Meeting, PA). Rab-
bit anti-CRT was from Thermo Scientific 
(Waltham, MA). Rabbit mAb anti–glyceral-
dehyde-3-phosphate dehydrogenase was 
from Cell Signaling (Beverly, MA). Rabbit 
anti-BiP was from P. Arvan. Rabbit anti-CNX 
(used for IP) antibody was a kind gift from 
A. Helenius (Institute of Biochemistry, ETH 
Zürich, Zurich, Switzerland). Rabbit poly-
clonal anti-UGGT1 antibody was a kind gift 
from A. Parodi (Laboratory of Glycobiology, 
Fundación Instituto Leloir, Buenos Aires, 
Argentina). Mouse monoclonal anti-antit-
rypsin polymer antibody (2C1) was a kind 
gift from E. Miranda (Dipartimento di Biologia 
e Biotecnologie ‘‘Charles Darwin’’ and 
Istituto Pasteur-Fondazione Cenci Bolog-
netti, Universita di Roma ‘‘La Sapienza,’’ 
Rome, Italy) and D. Lomas (Department of 
Medicine, University of Cambridge, 
Cambridge Institute for Medical Research, 
Cambridge, UK).
cDNAs and constructs
NHK and ATZ mutant constructs were 
made by QuikChange mutagenesis (Strata-
gene, Santa Clara, CA) from wt-AAT in 
pcDNA3.1 using standard methods. 
wt-AAT, NHK, and ATZ constructs were 
modified by S. H. Back (School of Biologi-
cal Sciences, University of Ulsan, Ulsan, 
Republic of Korea) to express AAT and 
enhanced green fluorescent protein as two 
separate proteins from a single mRNA by 
cap-dependent and internal ribosome 
entry site–dependent translation. UGGT1 
and variants were previously published 
(Arnold and Kaufman, 2003). NHK N-gly-
cosylation–site mutants were constructed 
using the QuikChange Lightning Multi Site-
Directed Mutagenesis Kit (Stratagene).
Cell culture
Uggt1−/− MEFs (Molinari et al., 2005) were 
maintained in DMEM (Life Technologies, 
Carlsbad, CA) supplemented with 10% fetal 
FIGURE 8: Calreticulin siRNA knockdown reduces UGGT1-mediated increased solubility of NHK. 
(A) Tandem anti-AAT/anti-CRT IP of soluble material from Uggt1−/− MEFs cotransfected with NHK 
and UGGT1 and treated with or without DSP cross-linking. The results demonstrate association 
between NHK and CRT. (B) Effect of CRT knockdown on chaperone expression. CRT siRNA 
transfection greatly reduces the amount of CRT protein without any compensatory increase in 
CNX, BiP, or GRP94 protein. (C) Steady-state labeling analysis of Uggt1−/− MEFs transfected with 
CRT or NegCtrl siRNAs and cotransfected with NHK and either UGGT1 or empty vector 
(Materials and Methods). (D) Quantification of C, each fraction represented as proportion of 
total. (E) The effect of UGGT1 on the total soluble/insoluble ratio of NHK upon CRT knockdown. 
Student’s t test was used for statistical testing (*p ≤ 0.05). Error bars represent SEM.
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was added to the pellet/SDS mixture, 
followed by centrifugation at 10,000 × g for 
10 min at room temperature. Unless indi-
cated otherwise, equal proportions of each 
fraction were used for IP.
Pulse-chase analysis
Uggt1−/− MEFs were transfected as for 
steady-state labeling, but the starvation, 
pulse, and chase were performed 24 h after 
transfection. Preparation of soluble and in-
soluble fractions and double anti-AAT IP 
were similar to steady-state labeling analy-




Trichloroacetic acid (TCA)-normalized vol-
umes of extracellular, soluble, and insoluble 
fractions were incubated at 4°C overnight 
with anti-AAT antibody plus protein A–Sep-
harose. Beads were washed three times with 
ice-cold 0.5% CHAPS/HBS, pH 7.4, and 
then the wash was removed completely by 
careful aspiration with a small-bore pipette 
tip. To reduce background, antigen–anti-
body complexes were disrupted using the 
previously described 1% SDS/1% Triton X-100 resuspension method, 
and 1 ml of this supernatant was then incubated overnight at 4°C 
with anti-AAT antibody plus protein A–Sepharose, then washed and 
dried by aspiration (double IP). In most cases, beads were then sub-
jected to PNGaseF digestion for 1 h, and then 3 μl of 5× sample 
buffer plus dithiothreitol was added, and this bead suspension was 
boiled at 95°C for 5 min. Bead supernatants were analyzed by SDS–
PAGE on 10% Tris-HCl Criterion gels or Mini-PROTEAN gels (Bio-
Rad, Hercules, CA) at 200 V for 40 min. Gels were then Coomassie 
stained, destained, and dried in a gel-vacuum dryer for 2 h at 80°C. 
Finally, dried gels were exposed to a phosphor screen overnight 
and imaged on a Typhoon imager (GE Healthcare, Piscataway, NJ), 
and bands were quantified with ImageQuant (GE Healthcare).
DSP cross-linking
At 48 h posttransfection, NHK transfected cells were cross-linked in 
2 mM DSP in 4% DMSO/96% PBS for 30 min at room temperature. 
Soluble and insoluble fractions were prepared, and TCA-normalized 
volumes were subjected to anti-AAT double IP and analyzed by re-
ducing SDS–PAGE (breaks DSP cross-link).
BiP-luciferase assay
ER stress response was measured 48 h posttransfection using BiP-
luciferase expression plasmid (Tirasophon et al., 1998) and a Dual-
Luciferase Reporter Assay System (Promega, Madison, WI), and a 
parallel set of wells was steady-state labeled to determine total in-
tracellular AAT in each transfection group.
Immunofluorescence
Uggt1−/− MEFs were transfected with ATZ ± UGGT1 cotransfection, 
plated on chamber slides, and fixed with 4% paraformaldehyde solu-
tion 48 h posttransfection. Cells were permeabilized and blocked in 
blocking buffer (1% bovine serum albumin, 0.1% Triton X-100, 0.01% 
NaN3 in PBS) for 1 h and incubated overnight with 2C1 culture media 
bovine serum and Glutamax (Life Technologies). Cells were cultured 
at 37°C in a 5% CO2 incubator.
Steady-state metabolic labeling/pulse-labeling analysis
Uggt1−/− MEFs were transiently transfected using Lipofectamine 
2000 transfection reagent (Life Technologies) with AAT constructs 
and either UGGT1 (1:3 M ratio AAT:UGGT1) or an equal microgram 
amount of empty vector (pEDΔC). The next day, cells were trypsinized 
and plated in separate six-well plates for pulse labeling or steady-
state analysis. Complete medium supplemented with 0.1 mCi/ml 
[35S]methionine and [35S]cysteine (Tran35S-label; MP Biomedicals, 
Solon, OH) was added to steady-state wells 24 h posttransfection, 
and media and cells were collected 48 h posttransfection (steady-
state labeling). Cells in the remaining wells were starved for 20 min 
in media lacking Met/Cys, pulsed for 20 min with starvation medium 
supplemented with 0.1 mCi/ml [35S]Met/Sys, and collected in the 
same manner as described next for steady-state labeling.
For each well, medium was collected on ice and centrifuged at 
10,000 × g for 10 min at 4°C, and this cleared supernatant was called 
the extracellular fraction. Cells were lysed in 550 μl 2%CHAPS/HBS 
(50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 200 nM 
NaCl), pH 6.8, plus 200 mM PMSF, 20 mM NEM, and protease 
inhibitors (10 μg/ml final concentration chymostatin, leupeptin, anti-
pain, and pepstatin A) for 20 min on ice. Cells were scraped from the 
wells with a rubber policeman, and lysate was transferred to a cen-
trifuge tube. Then 100 μl of lysis buffer was used to wash the well 
(to collect as much cellular material as possible), and this wash was 
added to the same centrifuge tube. Lysates were centrifuged at 
10,000 × g for 10 min at 4°C, and the supernatant was transferred to 
a new tube and called the soluble fraction. Pellets from this centrifu-
gation step were washed with 150 μl of lysis buffer and centrifuged 
at 10,000 × g for 10 min at 4°C, and then the wash was removed. 
Pellets were then solubilized by addition of 100 μl of 1% SDS, soni-
cated, and boiled at 95°C for 5 min. One milliliter of 1% Triton X-100 
FIGURE 9: UGGT1 promotes solubility of glycoproteins by promoting interaction with CNX and 
CRT. Model depicting the role of UGGT1 in promoting solubility of glycoproteins by promoting 
interaction with CNX and CRT. Monoglucosylated NHK is found only in the soluble fraction and 
not in the insoluble fraction. NHK is associated with CRT and CNX in the presence of UGGT1, 
and this interaction may be a mechanism for maintaining solubility of NHK. Therefore, at the 
hypothesized decision point at which unglucosylated NHK can exit the ER, be degraded by 
ERAD, form insoluble aggregates, or be monoglucosylated by UGGT1, we hypothesize that 
UGGT1 promotes a decision by NHK to remain soluble.
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supernatant (1:10) and anti-AAT antibody (1:1000) in blocking buffer. 
Secondary antibody (Alexa 350, 555; 1:1000; Invitrogen, Carlsbad, 
CA) incubation was at room temperature for 1 h. Slides were imaged 
on an Olympus FV500 confocal microscope with FluoView software 
(Olympus, Tokyo, Japan). Z-stack analysis was performed using 
MetaMorph software (Molecular Devices, Sunnyvale, CA).
siRNA knockdown experiment
Uggt1−/− MEFs were transfected with Lipofectamine RNAiMAX 
transfection reagent (Life Technologies) at 0 h with either an equal 
mixture of two nonoverlapping CRT siRNAs (Silencer Select; Life 
Technologies) or nontargeting negative control no. 1 siRNA at a 
10 nM final concentration in transfection media. Each transfection 
group was then transfected with Lipofectamine 2000 at 48 h with 
DNA expression plasmids plus the same siRNAs as the 0-h transfec-
tion. Cells were trypsinized and split into two groups. One group 
was steady-state labeled from 72 to 96 h, and the other group was 
collected for immunoblot analysis at 96 h.
Statistical analysis
Student’s t test was used throughout with Prism software (GraphPad 
Software, La Jolla, CA).
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